| |
| |
|
| Insider
Information: |
Bancroft Charles A |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
168,937 |
|
|
Indirect Shares
|
300,000 |
|
|
| Direct
Value |
$6,424,696 |
|
|
|
Indirect Value
|
$12,702,000 |
|
|
| Total
Shares |
468,937 |
|
|
| Total
Value |
$19,126,696 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bristol-Myers Squibb Co |
BMY |
EVP, Head of Integration |
2020-03-10 |
137,534 |
2020-03-10 |
300,000 |
Premium* |
|
|
Colgate Palmolive Co |
CL |
Director |
2018-05-14 |
5,455 |
2017-05-15 |
0 |
Premium* |
|
|
Kodiak Sciences Inc. |
KOD |
Director |
2020-04-02 |
25,948 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
117 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
• – – |
2016-12-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,403 |
192,801 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
• – – |
2017-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
3,196 |
224,650 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
• – – |
2017-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,659) |
229,647 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
• – – |
2017-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
87,324 |
289,293 |
0 |
- |
|
| CL |
Colgate Palmolive Co |
Director |
• • – |
2017-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
2,512 |
2,512 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
• – – |
2017-12-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,401 |
267,770 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
• – – |
2018-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
91,318 |
363,739 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
• – – |
2018-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
3,469 |
302,298 |
0 |
- |
|
| CL |
Colgate Palmolive Co |
Director |
• • – |
2018-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
2,901 |
5,455 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
• – – |
2018-12-02 |
4/A |
OE |
$0.00 |
$0 |
D/D |
6,401 |
342,522 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
• – – |
2018-12-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,401 |
206,117 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
• – – |
2019-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
62,255 |
411,547 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
• – – |
2019-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(4,735) |
376,895 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, Head of Integration |
• – – |
2020-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
7,075 |
158,045 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, Head of Integration |
• – – |
2020-03-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
300,000 |
92,309 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, Head of Integration |
• – – |
2020-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
71,868 |
153,637 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, Head of Integration |
• – – |
2020-03-10 |
4 |
GA |
$0.00 |
$0 |
I/I |
300,000 |
300,000 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, Head of Integration |
• – – |
2020-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(397) |
106,408 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
• – – |
2019-02-28 |
4 |
OE |
$17.51 |
$925,999 |
D/D |
52,884 |
392,690 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
• – – |
2018-02-23 |
4 |
OE |
$22.14 |
$829,364 |
D/D |
37,460 |
302,348 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
• – – |
2014-02-14 |
4 |
OE |
$22.73 |
$870,038 |
D/D |
36,251 |
130,266 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
• • – |
2012-12-17 |
4 |
OE |
$23.14 |
$1,191,115 |
D/D |
47,125 |
113,920 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Acting CFO |
• – – |
2010-03-04 |
4 |
D |
$24.57 |
$18,329 |
D/D |
(746) |
24,647 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Acting CFO |
• – – |
2010-03-06 |
4 |
D |
$24.60 |
$12,644 |
D/D |
(514) |
25,545 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Acting CFO |
• – – |
2010-03-07 |
4 |
D |
$24.60 |
$10,480 |
D/D |
(426) |
25,119 |
0 |
- |
|
117 Records found
|
|
Page 3 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
